Literature DB >> 34448809

Identification of Genetically Related HCV Infections Among Self-Described Injecting Partnerships.

Damien C Tully1,2, Judith A Hahn3, David J Bean4, Jennifer L Evans5, Meghan D Morris5, Kimberly Page6, Todd M Allen4.   

Abstract

BACKGROUND: The current opioid epidemic across the United States has fueled a surge in the rate of new hepatitis C virus (HCV) infections among young persons who inject drugs (PWIDs). Paramount to interrupting transmission is targeting these high-risk populations and understanding the underlying network structures facilitating transmission within these communities.
METHODS: Deep sequencing data were obtained for 52 participants from 32 injecting partnerships enrolled in the U-Find-Out (UFO) Partner Study, which is a prospective study of self-described injecting dyad partnerships from a large community-based study of HCV infection in young adult PWIDs from San Francisco. Phylogenetically linked transmission events were identified using traditional genetic-distance measures and viral deep sequence phylogenies reconstructed to determine the statistical support of inferences and the direction of transmission within partnerships.
RESULTS: Using deep sequencing data, we found that 12 of 32 partnerships were genetically similar and clustered. Three additional phylogenetic clusters were found describing novel putative transmission links outside of the injecting relationship. Transmission direction was inferred correctly for 5 partnerships with the incorrect transmission direction inferred in more than 50% of cases. Notably, we observed that phylogenetic linkage was most often associated with a lower number of network partners and involvement in a sexual relationship.
CONCLUSIONS: Deep sequencing of HCV among self-described injecting partnerships demonstrates that the majority of transmission events originate from outside of the injecting partnership. Furthermore, these findings caution that phylogenetic methods may be unable to routinely infer the direction of transmission among PWIDs especially when transmission events occur in rapid succession within high-risk networks.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  deep sequencing; hepatitis C virus; injection drug use; molecular epidemiology; phylogenetic

Mesh:

Year:  2022        PMID: 34448809      PMCID: PMC8946742          DOI: 10.1093/cid/ciab596

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   20.999


  37 in total

1.  Notes from the field : hepatitis C virus infections among young adults--rural Wisconsin, 2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-05-18       Impact factor: 17.586

Review 2.  Self-report among injecting drug users: a review.

Authors:  S Darke
Journal:  Drug Alcohol Depend       Date:  1998-08-01       Impact factor: 4.492

3.  Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012.

Authors:  Anil G Suryaprasad; Jianglan Z White; Fujie Xu; Beth-Ann Eichler; Janet Hamilton; Ami Patel; Shadia Bel Hamdounia; Daniel R Church; Kerri Barton; Chardé Fisher; Kathryn Macomber; Marisa Stanley; Sheila M Guilfoyle; Kristin Sweet; Stephen Liu; Kashif Iqbal; Rania Tohme; Umid Sharapov; Benjamin A Kupronis; John W Ward; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2014-08-11       Impact factor: 9.079

4.  Frequent longitudinal sampling of hepatitis C virus infection in injection drug users reveals intermittently detectable viremia and reinfection.

Authors:  Kimberly Page; William Osburn; Jennifer Evans; Judith A Hahn; Paula Lum; Alice Asher; Eric Delwart; Leslie Tobler; Andrea L Cox; Michael P Busch
Journal:  Clin Infect Dis       Date:  2012-10-22       Impact factor: 9.079

5.  Hepatitis C virus seroconversion among young injection drug users: relationships and risks.

Authors:  Judith A Hahn; Kimberly Page-Shafer; Paula J Lum; Philippe Bourgois; Ellen Stein; Jennifer L Evans; Michael P Busch; Leslie H Tobler; Bruce Phelps; Andrew R Moss
Journal:  J Infect Dis       Date:  2002-11-04       Impact factor: 5.226

6.  A large HCV transmission network enabled a fast-growing HIV outbreak in rural Indiana, 2015.

Authors:  Sumathi Ramachandran; Hong Thai; Joseph C Forbi; Romeo Regi Galang; Zoya Dimitrova; Guo-Liang Xia; Yulin Lin; Lili T Punkova; Pamela R Pontones; Jessica Gentry; Sara J Blosser; Judith Lovchik; William M Switzer; Eyasu Teshale; Philip Peters; John Ward; Yury Khudyakov
Journal:  EBioMedicine       Date:  2018-11-15       Impact factor: 8.143

7.  Inferring HIV-1 transmission networks and sources of epidemic spread in Africa with deep-sequence phylogenetic analysis.

Authors:  Oliver Ratmann; M Kate Grabowski; Matthew Hall; Tanya Golubchik; Chris Wymant; Lucie Abeler-Dörner; David Bonsall; Anne Hoppe; Andrew Leigh Brown; Tulio de Oliveira; Astrid Gall; Paul Kellam; Deenan Pillay; Joseph Kagaayi; Godfrey Kigozi; Thomas C Quinn; Maria J Wawer; Oliver Laeyendecker; David Serwadda; Ronald H Gray; Christophe Fraser
Journal:  Nat Commun       Date:  2019-03-29       Impact factor: 14.919

8.  Hepatitis C virus phylogenetic clustering is associated with the social-injecting network in a cohort of people who inject drugs.

Authors:  Rachel Sacks-Davis; Galina Daraganova; Campbell Aitken; Peter Higgs; Lilly Tracy; Scott Bowden; Rebecca Jenkinson; David Rolls; Philippa Pattison; Garry Robins; Jason Grebely; Alyssa Barry; Margaret Hellard
Journal:  PLoS One       Date:  2012-10-26       Impact factor: 3.240

9.  Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012.

Authors:  Jon E Zibbell; Kashif Iqbal; Rajiv C Patel; Anil Suryaprasad; Kathy J Sanders; Loretta Moore-Moravian; Jamie Serrecchia; Steven Blankenship; John W Ward; Deborah Holtzman
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-05-08       Impact factor: 17.586

10.  Intimate injection partnerships are at elevated risk of high-risk injecting: a multi-level longitudinal study of HCV-serodiscordant injection partnerships in San Francisco, CA.

Authors:  Meghan D Morris; Jennifer Evans; Martha Montgomery; Michelle Yu; Alya Briceno; Kimberly Page; Judith A Hahn
Journal:  PLoS One       Date:  2014-10-06       Impact factor: 3.240

View more
  1 in total

1.  Leveraging genomic surveillance to enhance elimination strategies for hepatitis C virus.

Authors:  Damien C Tully
Journal:  Lancet Microbe       Date:  2022-08-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.